期刊文献+

顺铂通过激活细胞外信号调节激酶(ERK)通路促进A549人肺腺癌细胞PD-L1表达 被引量:5

Cisplatin promotes PD-L1 expression in A549 human lung adenocarcinoma cells via activating the ERK pathway
下载PDF
导出
摘要 目的探讨顺铂(DDP)对人肺腺癌A549细胞的程序性死亡蛋白1配体1(PD-L1)表达的影响及其可能的机制。方法体外培养人肺腺癌A549细胞,采用(0、0.5、1、2、4、8)mg/L DDP处理24、36、48 h,CCK-8法检测细胞增殖抑制率,并计算其半数抑制浓度(IC_(50)),选择最适抑制时间48 h及其IC_(50)用于后续实验。后续将A549细胞分为4组:空白对照组、IC_(50)的DDP组、20μmol/L的丝裂原活化蛋白激酶激酶抑制剂PD98059组、IC_(50)的DDP联合20μmol/L PD98059组。培养48 h,Western blot法检测细胞外信号调节激酶(ERK)、磷酸化的ERK(p-ERK)蛋白表达,流式细胞术检测PD-L1表达。结果与对照组相比,DDP处理的A549细胞PD-L1表达均上调,且呈剂量依赖性,选择最适作用时间点为48h,其IC_(50)值为3.586 mg/L。与对照组相比,DDP处理组p-ERK、PD-L1表达增加,PD98059组p-ERK表达降低;DDP联合PD98059组较DDP组的p-ERK、PD-L1的表达降低,较PD98059组的p-ERK、PD-L1表达增加。结论DDP激活ERK信号通路上调A549细胞PD-L1表达。 Objective To investigate the effect of cisplatin(DDP)on the expression of programmed death 1 ligand 1(PD-L1)in human lung adenocarcinoma A549 cells and its possible mechanism.Methods Human lung adenocarcinoma A549 cells were cultured in vitro and treated with(0,0.5,1,2,4,8)mg/L of DDP for 24,36,48 hours.CCK-8 assay was used to detect the cell proliferation inhibition rate and the half maximal inhibitory concentration(IC_(50))was calculated.The optimal inhibition time of 48 hours and its IC_(50)were selected for subsequent experiments.A549 cells were then randomized into four groups:blank control group,group with DDP(IC_(50)),group with 20μmol/L of mitogen-activated protein kinase kinase inhibitor PD98059,and group with DDP(IC_(50))combined with 20μmol/L of PD98059.The cells were cultured for 48 hours.The expression of ERK and p-ERK were detected by Western blotting,and PD-L1 expression was detected by flow cytometry.Results Compared with that in the control group,the expression of PD-L1 in A549 cells treated with DDP was up-regulated in a dose-dependent manner.The optimal time was 48 hours and the IC_(50)was 3.586 mg/L.Also compared with that in the control group,the expression of p-ERK and PD-L1 in the DDP treatment group increased,and the expression of p-ERK in the group with PD98059 decreased.The expressions of p-ERK and PD-L1 in the group with DDP combined with PD98059 were lower than those in the group with DDP,but higher than those in the group with PD98059.Conclusion DDP up-regulates the expression of PD-L1 in A549 cells by activating the ERK signaling pathway.
作者 朱虹 刘单 邓述恺 ZHU Hong;LIU Dan;DENG Shukai(Department of Respiration,First Affiliated Hospital of Southwest Medical University,Luzhou 646000,China)
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2021年第10期891-896,共6页 Chinese Journal of Cellular and Molecular Immunology
基金 西南医科大学自然科学青年基金(2017-ZRQN-075)。
关键词 肺肿瘤 A549细胞 顺铂(DDP) 程序性死亡蛋白1配体1(PD-L1) 细胞外信号调节激酶(ERK) lung tumor A549 cell cis-diamminodichloroplatinumⅡdichloride(DDP) programmed death 1 ligand 1(PD-L1) ERK
  • 相关文献

参考文献1

二级参考文献15

  • 1孙德彬,留静.顺铂联合吉西他滨对肺癌PD-1/PD-L1途径的影响[J].中国生化药物杂志,2014,34(5):50-53. 被引量:12
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63( 1 ) : 11-30.
  • 3Moro-Sibilot D, Audigier-Valette C, Merle P, et al. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens ( IFCT- 0702: A randomized phase 3 final results study) [ J ]. Lung Canc- er, 2015, 89(2): 139-145.
  • 4Wu P, Wu D, Li L, et al. PD-L1 and survival in solid tumors: A recta-analysis [ J/OL ]. PLoS One, 2015 [ 2015-09-22 ]. http://journals.plos, org/plosone/article? id = 10. 1371/journal. pone.0131403.
  • 5Bobbio A, Alifano M. Immune therapy of non-small cell lung cancer: The future[J]. Pharmacol Res, 2015, 99: 217-222.
  • 6Hanahan D, Weinberg RA. Hallmarks of cancer: the next gener- ation[J]. Cell, 2011, 144(5) : 646-674.
  • 7Lu W, Lu L, Feng Y, et al. Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1surface expression[J]. Oncol Lett, 2013, 5(5) : 1519-1526.
  • 8SznolM, Chen L. Antagonist antibodies to PD-land B7-H1 (PD- L1 ) in the treatment of advanced human cancer response [ J ]. Clin Cancer Res, 2013, 19(19): 5542.
  • 9Qin X, Liu C, Zhou Y, et al. Cisplatin induces programmed death-l-ligand 1 ( PD-L1 ) over-expression in hepatoma H22 cells via Erk./MAPK signaling pathway [ J ]. Cell Mol Biol ( Noisy-le- grand), 2010, 56(Snppl) : 1366-1372.
  • 10Ghebeh H, Lehe C, Barhoush E, et al. Doxorubicin downregu- lares cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apop- totic molecule[ J/OL]. Breast Cancer Res, 2010[ 2015-09-22]. http ://www. nebi. nlm. nih. gov/pmc/articles/pmid/20626886.

共引文献5

同被引文献33

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部